The FDA granted breakthrough therapy status to first-line petosemtamab plus pembrolizumab for PD-L1–positive recurrent or ...

A new study has evaluated the effectiveness of different treatment options for basal cell carcinoma. Learn more.

gmail.com This man in his early 70s presented with a six month history of a pigmented lesion on the gum. He reported no associated pain, bleeding, or constitutional symptoms. On examination, there was ...

Introduction: The genetic wealth present in pigmented rice varieties offer abundant ... The bioactivity of samples was tested against colon carcinoma (HCT116) and lung adenocarcinoma (A549) cell lines ...

The Sporting News details everything you need to know about McDermott's battle with skin cancer. McDermott first revealed in 2021 that he had squamous cell carcinoma "several times." He added ...

Cutaneous squamous cell carcinoma (cSCC) is the second most common non-melanoma skin cancer, among which 82% arise from actinic keratosis (AK) characterized by lesions of epidermal keratinocyte ...

Brazilian Nuclear Energy Commission, Institute of Nuclear Engineering, Laboratory of Nanoradiopharmacy and Synthesis of New Radiopharmaceuticals, Rio de Janeiro 21941906, Brazil State University of ...